Using Digital Therapeutics to Treat Substance Use Disorders
The convenience and confidentiality of computer-based and mobile technologies may encourage more individuals with substance use disorders to access treatment.
Opioid-Related Disorder
Treatment Rates Low for Parents With Opioid Use Disorder
Rates of treatment are low for parents with opioid use disorder (OUD) or other substance use disorders.
Heroin Overdose ED Visits Decreased From 2017 to 2018
From 2017 to 2018, there was a decrease in heroin overdose emergency department visits, although the declines were not consistent among states.
Naltrexone XR May Be Associated With Dysphoria, Suicide Ideation
Monthly injections of naltrexone extended-release may induce a dysphoric state and suicidal ideation in some patients.
Machine-Learning Algorithms May Accurately Predict Risk for Opioid Overdose
Machine-learning algorithms that incorporate administrative data and deep learning may be effective for predicting risk for opioid overdose and for identifying patients at low risk for overdose.
First Generic Naloxone Nasal Spray Gets FDA Approval
The FDA has granted final approval for the first generic version of Narcan (naloxone hydrochloride nasal spray; Adapt Pharma) to Teva Pharmaceuticals.
Mortality Rates Related to Synthetic Opioids Rising in Eastern United States
Opioid-related deaths, particularly those associated with synthetic opioids, increased in the eastern United States between 1999 and 2016, leading to lower life expectancies.
Regional Variance in Prevalence of Opioid Use Disorder Diagnosis, Treatment During Pregnancy
The presence of civil or criminal penalties for OUD diagnosis during pregnancy was associated with the prevalence of OUD diagnosis.
Plasma Levels of Naloxone Compared Using Various Administration Methods
According to the results of a recently published study, FDANxSpray, the FDA-approved Narcan device for nasal administration, was found to yield higher plasma concentrations of naloxone compared to other devices used to treat opioid overdoses.
Substitution of Opioids With Cannabis Not Recommended for Treating Addiction
The current evidence for the efficacy and safety of replacing opioids with medical cannabis for treating opioid addiction does not meet standards for recommendation.
Next post in Addiction
